Yakup Ergün/obdh.com.tr
May 9, 2025, 09:39
Yakup Ergün: One of the Key Upcoming Presentations at ESMO Breast 2025
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X:
“ESMO Breast 2025 is in 5 Days!
One of the key upcoming presentations:
EMBER-3 Subgroup Analysis
- Imlunestrant + abema improved PFS after CDK4/6i (vs. Imlu)
- No abema benefit after abema
- Efficacy observed after palbo and ribo
- Consistent benefit in ESR1+ and PI3K-mutant patients.”
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared this post, adding:
“Careful about drawing conclusions on abema after abema based on 23 patients. The HR confidence intervals are incredibly wide (0.37 – 2.31).”
More posts featuring Yakup Ergün and Paolo Tarantino.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 2, 2025, 18:07
Jun 2, 2025, 18:00
Jun 2, 2025, 17:43
Jun 2, 2025, 17:18
Jun 2, 2025, 17:06
Jun 2, 2025, 15:40
Jun 2, 2025, 15:37
Jun 2, 2025, 15:20